Synthetic Peptide Drugs for Targeting Skin Cancer: Malignant Melanoma and Melanotic Lesions

E-ISSN： 1875-533x|24|17|1797-1826

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.17, 2017-07, pp. : 1797-1826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic Lesions in Malignant Melanoma

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 6, 2007-12 ,pp. : 382-387

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs targeting integrins for cancer therapy

By Binder Mascha Trepel Martin

Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. : 229-241

Informa Healthcare

Access to resources Recommend Favorite

Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma

By Sharma Bhawna Singh Seema Varney Michelle L Singh Rakesh K

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 4, 2010-04 ,pp. : 435-442

Informa Healthcare

Access to resources Recommend Favorite

Photodynamic Therapy for Non-Melanoma Skin Cancer

By Fien Sari M. Oseroff Allan R.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 5, 2007-05 ,pp. : 531-540

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Malignant Melanoma

By PARKER TIMOTHY ZITELLI JOHN

Dermatologic Surgery, Vol. 22, Iss. 3, 1996-03 ,pp. : 234-240

Elsevier

Access to resources Recommend Favorite